Results 51 to 60 of about 18,399 (161)

Tratamiento de la emesis inducida por citotóxicos

Psicooncologia, 2004
Nausea and vomiting are important side effects of most chemotherapy anticancer drugs, since nearly two thirds of the patients under chemotherapy have this toxicity in absence of antiemetic treatment.
Miguel Martín, Sara López
doaj  

Dispensing of Antiemetics During Pregnancy in Aotearoa New Zealand, 2005-2020. [PDF]

Aust N Z J Obstet Gynaecol
Donald S, Sharples K, Barson D, Maclennan K, Te Karu L, Phone D, van Asten H, Stitely M, Parkin L.   +8 more
europepmc   +1 more source

Persistent nausea burden at peak antiemetic therapy in palliative care: an exploratory study. [PDF]

BMC Palliat Care
Pietsch P, Summerer L, Mair R, Müller K, Authier D, Herr W, Rechenmacher M, Schnell A.   +7 more
europepmc   +1 more source

Impact of Evolving Antiemetic Prophylaxis on Chemotherapy-Induced Nausea and Vomiting (CINV): A Five-Year Comparative Study in Sichuan, China (2018-2023). [PDF]

Cancer Manag Res
Xiong W, Zhang W, Zhao Q, Zheng Y, Xie K, Miao J, Chen L, Li T, Cao W, Zhu, Huang M, Li C, Wang Y, Gui Y, Li Q, Cao C, Yang Y, Du C, Gao Y, Zhou Y, Zhang H, Le X, Chen P, Jiang M, Li P, Yang J, Wang Y, Zhu J, He L.   +28 more
europepmc   +1 more source

Perioperative Anesthesia Strategies for the Prevention of Postoperative Nausea and Vomiting Within Enhanced Recovery After Surgery Pathways: A Clinical Narrative Review. [PDF]

J Clin Med
Dombrower R, McKenzie A, Tucker AJ, Atwell J.   +3 more
europepmc   +1 more source

Fosnetupitant for long-delayed chemotherapy-induced nausea and vomiting in oxaliplatin-based regimens: a prospective observational study (LODEC-N). [PDF]

Cancer Chemother Pharmacol
Iimura Y, Iihara H, Aoyama T, Hayashi T, Ishibashi M, Sasuga C, Furukawa N, Anzai E, Ijichi Y, Kuroda S.   +9 more
europepmc   +1 more source

Moving beyond promethazine: Advancing precision in antiemetic therapy. [PDF]

SAGE Open Med
Ryan MF, Lagasse C.
europepmc   +1 more source

Efficacy of steroid-omitting antiemetic therapy in patients with advanced pancreatic cancer receiving nano-liposomal irinotecan plus fluorouracil and leucovorin. [PDF]

Support Care Cancer
Tokito Y, Ishigaki K, Nara K, Endo G, Nishio H, Fukuda K, Suzuki T, Sato Y, Takahara N, Boku N, Fujishiro M.   +10 more
europepmc   +1 more source

Comparative Efficacy of Fosnetupitant and Fosaprepitant for Delayed Vomiting in Patients Receiving Irinotecan-Oxaliplatin Combination Chemotherapy: A Retrospective Propensity Score-Matched Study. [PDF]

Cancer Manag Res
Maeda K, Kawada K, Hayashi T, Koyama S, Ishida T, Yoshioka T, Fukuda H, Horikawa I, Aizawa F, Niimura T, Yagi K, Goda M, Izawa-Ishizawa Y, Ishizawa K.   +13 more
europepmc   +1 more source

Efficacy of olanzapine for prophylaxis of delayed chemotherapy-induced nausea and vomiting in patients with breast cancer receiving dose-dense AC with a steroid-sparing regimen: a single-center pilot study. [PDF]

BMC Cancer
Tada M, Kikawa Y, Shibata N, Hirai C, Yanai H, Takada M, Sugie T.   +6 more
europepmc   +1 more source